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4 Septic shock is characterized by severe hypotension, hyporesponsiveness to vasoconstrictors and volume depletion leading to multiorgan dysfunction and death (Bone, 1994; Webber, 1998) . This condition is a complex endotoxin-induced systemic inflammatory response, which affects more than 400,000 patients per year in the United States (Knuefermann et al., 2002) . Cell wall-endotoxins such as bacterial lipopolysaccharide (LPS) are largely responsible for the pathogenesis of this disease. The endothelium and the vascular smooth muscle are among major cellular targets of LPS (Alexander and Rietschel, 2001 ).
The deleterious effects of LPS are often mediated by the enzymatic activity of LPS-inducible proteins such as inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9). Initially, these enzymes are induced in a highly organized fashion to compensate for the damaging effects of LPS and maintain homeostasis, and to contribute to the systemic inflammatory response. However, the overwhelming concentrations of these inducible enzymes can become harmful to the body, contributing to multiorgan dysfunction and death. The increased expression of iNOS, for example, results in massive vasodilatation and hypotension (Gomez-Jimenez et al., 1995; Titheradge, 1999) . Additionally, fast reaction of NO with superoxide (O -2 ) leads to the highly reactive species, peroxynitrite (ONOO -) (Beckman et al., 1990; Beckman and Koppenol, 1996) . The latter, is thought to be responsible for many deleterious effects of NO, acting as an oxidant itself or leading to the formation of other reactive species (Szabo et al., 1996) . Moreover, COX-2 upregulation leads to overproduction of thromboxane and prostaglandin E 2 (PGE 2 ), which have been implicated in the pathogenesis of septic shock (Ermert et al., 2000; Fischer et al., 2000; Strong et al., 2000) .
In the presence of LPS, cells like neutrophils secrete considerable amounts of latent MMPs, including MMP-9 (Albert et al., 2003) . Reactive oxygen species, produced by the same cell type, lead to the chemical activation of MMP-9 and as a consequence, degradation of the vascular wall takes place (Opdenakker, 2001 ).
Other lines of evidence from mice and humans have also correlated MMP-9 levels with shock conditions (Pugin et al., 1999; Dubois et al., 2002; Albert et al., 2003) .
Despite solid evidence that iNOS, COX-2 and MMP-9 are involved in the pathogenesis of cellular damage caused by LPS, the interactions (cross-talk) between these enzymes are unclear. We found that the simultaneous induction of these enzymes could be triggered by IFN-γ, PMA and LPS in rat vascular smooth muscle (VSM) cells, allowing us to study the hypothesis that these three enzymes cross-talk to each other. This article has not been copyedited and formatted. The final version may differ from this version. The production of these three enzymes was studied at the transcriptional level, at the protein level and at the enzyme activity level. The results of our experiments provide evidence that iNOS upregulates COX-2 and MMP-9 gene expression in VSM.
This article has not been copyedited and formatted. The final version may differ from this version. 10% fetal bovine serum (FBS) and gentamycin sulfate (0.05 mg/mL), penicillin G (0.06 mg/mL) and streptomycin sulfate (0.01 mg/mL). Cells were grown until they were confluent and then treated for 12 h with a cocktail containing 10 ng/mL IFN-γ, 1nM PMA, 10µg/mL LPS in 15mL of 1% FBS (activating cocktail).
When treating with dexamethasone (Dex), cells were pre-incubated with this chemical for 1 h prior to induction with the activating cocktail. Dex concentrations of 1.0, 3.0 and 10 µM were tested. At a concentration of 1µM, Dex did not confer inhibitory effects as detectable by RT-PCR. 3µM Dex was found to be sufficient to inhibit transcription of iNOS, COX-2 and MMP-9 and all consecutive experiments were performed using 3 µM Dex. When either L-NAME (300µM); ODQ (0.05, 0.1, 0.5, 1.0, and 5 µM); or superoxide dismutase (SOD) (0.5, 1, 5, 10, 100 U/mL) where used, these compounds were included in the activating cocktail. Cell harvesting was conducted by scraping cells off plates in the presence of 1mL homogenizing buffer (50 mM Tris-HCl, 320 mM sucrose, 1 mM dithiothreitol, 10 µg/mL leupeptin, 10 µg/mL soybean trypsin inhibitor, 2 µg/mL aprotinin, pH 7.4).
Gelatin Zymography: This technique was used to measure pro and active MMP-2 and MMP-9 gelatinolytic activity as previously described (Radomski et al., 1998) . After cell extraction, samples were immediately subjected to electrophoresis on 7% SDS-PAGE co-polymerized with gelatin (2mg/mL) as the substrate.
Independent experiments were performed and run on the same gel. Following electrophoresis, gels were washed in Triton X-100 (0.1%; 3 times, 20 min). The gels were then incubated for 72 h in the zymography buffer containing 25mM Tris/Cl, 5mM CaCl 2 , 142mM NaCl and 0.5mM Na 3 N to determine the activity of secreted enzymes. After incubation, the gels were stained with 0.05% Coomassie brilliant blue G-250 in a mixture of methanol: acetic acid: water (2.5: 1: 6.5) and destained in 4% methanol with 8% acetic acid. The
This article has not been copyedited and formatted. The final version may differ from this version. (Radomski et al., 1993) . Briefly, samples were homogenized by sonication (VibraCell, Danbury, CT) in 1 mL of ice-cold homogenizing buffer followed by centrifugation at 10,000 x g for 20 min at 4 ºC. Following centrifugation, 40 µl of supernatant was incubated at 37ºC for 20 min in assay buffer (pH 7.4) containing 50 mM KH 2 PO 4 , 1 mM MgCl 2 , 0.2 mM CaCl 2 , 1 mM L-citrulline, 20 µM Larginine, 1.5 mM dithiothreitol, 1.5 mM NADPH, 10 µM tetrahydrobiopterin, 10 µM FAD, 10 µM FMN and
The specificity of L-arginine conversion by NOS to L-citrulline was further confirmed using 1.2 mM N ω -nitro-L-arginine methyl ester, a selective inhibitor of NOS. Additionally, 1.5 mM EGTA, a calcium chelating agent, was used to differentiate between Ca
2+
-dependent and -independent isoforms of NOS. All enzyme activities were expressed as pmol product generated per min per mg protein.
The limit of detection of this method was 0.05 pmol/min/mg protein.
Griess assay: Formation of NO 2 -was measured as previously described (Gilchrist et al., 2002) . Briefly, 50µl
of supernatant was measured by the Griess reaction. Results were expressed as µM/10 6 cells following incubation for 6, 12, 24, 48 and 72h. Equal volumes of cell-free supernatant and Griess reagent (1% sulfanilamine, 0.1% N-(1-naphyl)-ethylene-diamine dihydrochloride, 2.5% H 3 PO 4 ) were mixed. NaNO2 was used as a standard. Plates were read on a Vmax kinetic microplate reader (Molecular Devices Co., Menol Park, CA) at 540 nm.
Live-cell fluorescence determination of intracellular NO: NO production by A7r5 was assayed using DAF-FM, a cell-permeable NO-sensitive fluorescent dye as previously described (Grisham et al., 1999) . Cells were incubated for 1h with 10µM DAF-FM, prior to visualization.
Cyclooxygenase-2 enzyme immuno assay: The activity of COX-2 was measured using a prostaglandin E 2 enzyme-immunoassay kit ( homogenates were subjected to 7% SDS-PAGE (Radomski et al., 1998) and proteins were identified using anti-MMP-9 antibodies (0.2µg/mL; Oncogen Science), anti-COX-2 antibodies (2µg/mL; Santa Cruz Biotechnology Inc) and anti-iNOS antibodies (0.125µg/mL; BD Transduction Laboratories).
RT-PCR and quantitative real time PCR: Experiments were performed as previously described (Szkotak et al., 2001 ). Total RNA was isolated using the Qiagen RNeasy kit. The RNA was reverse transcribed with the use of Superscript II reverse transcriptase (Gibco BRL) using oligo(dT) as primers. Thereafter, PCR was performed in 20µL reactions with the primer pairs (25 µM) described in Table 1 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific primers were run in all reactions as the internal positive control. The PCR products were amplified for 30 cycles. The selected cycle number was chosen to stop the PCR reaction during its log phase to ensure availability of all reagents. Additional RT-PCR-related information is summarized in Table 1 .
Quantitative Real Time PCR: Real time PCR experiments were performed using the TaqMan  TM quantitative RT-PCR reaction (Applied Biosystems) as previously described (Ritzel et al., 2001) . Briefly, an oligonucleotide probe, labeled with a fluorescent tag at the 5'-end and a quenching molecule at the 3'-end, is hybridized between two PCR primers at the beginning of the reaction. The 5'-nucleotidase activity of Taq polymerase, cleaves the fluorescent dye from the probe during each PCR cycle. The fluorescent signal generated is monitored in real time and is proportional to the amount of starting template in the sample. Real time PCR products were cloned and sequenced to confirm the identity of the mRNAs. The primer and probe sequences are summarized in Table 2 .
Reagents: Other PCR related chemicals such as 100 bp DNA ladder, superscript II, Taq DNA polymerase, and oligo(dT) primer were obtained from Gibco BRL; whereas dNTP and RNaseOUT ribonuclease were obtained from Invitrogen. Phorbol 12-myristate13-acetate (PMA), ethidium bromide, interferon-gamma,
quinoxalin-1-one (ODQ), and superoxide dismutase were obtained from Sigma (Oakville, Ontario, Canada).
Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin mentachloride (MnTMPyP) and guanosine 3',5'-cyclic monophosphate 8-bromo (8-bromo-cGMP) were obtained from Calbiochem (Mississauga, Ontario Canada).
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Results:
Since the objective of this research was to investigate the interactions between COX-2, iNOS and MMP-9 in VSM we have first tested various combinations of cytokine/inducing agents to cause simultaneous induction of these enzymes. The following combinations have been tested. A concentration gradient of 0.01, 0.1, 1 and 10µg/mL LPS did not produce a band detectable by zymography or RT-PCR for MMP-9, but constitutive MMP-2 activity was constant for every treatment (data not shown). 100nM PMA produced detectable bands for MMP-9 through RT-PCR and zymography, but did not activate iNOS mRNA as detectable by RT-PCR (data not shown). IFN-γ at a concentration of 1 mg/mL did not induce any of the mRNA signals for iNOS, COX-2 or MMP-9 (data not shown). After these preliminary experiments a combination containing 0.1ng/mL IFN-γ, 10 µg/mL LPS and 1nM PMA was found to be most effective in enzyme induction and all subsequent experiments were performed with cells stimulated with IFN-γ, LPS and PMA. Initial experiments were done using this cocktail and a time course for MMP-9 activity indicated optimal expression by 12h after activation (data not shown).
A time course of NO 2 -formation using the Griess reaction showed that there was a significant increase in nitrite formation after 24h (13.9±6.03µM) and after 48h (37.6±1.2µM) of cell activation. Nitrite formation was not detected in control conditions or when activated cells were co-treated with either L-NAME (300 µM) or 1400W (10nM) (n = 3). A more sensitive fluorimetric assay using the fluorochrome DAF showed NO production by 12h after cell induction (Fig. 1 ).
To study enzyme induction at the transcriptional level, Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was used. Primers were developed and analyzed using the BLAST sequencing program at Grenbank to ensure unique complementation. When A7r5 cells were exposed to the activating cocktail, the mRNAs for iNOS, COX-2 and MMP-9 were markedly upregulated ( Fig. 2-A and 2-B) . The PCR products for all templates were identified at their predicted molecular weights of 241, 347, 664 and 528bp for MMP-9, iNOS, COX-2 and GAPDH, respectively ( Fig. 2-A) . The induction of iNOS, COX-2 and MMP-9 mRNAs was significantly inhibited by 3µM Dex (Fig. 2-B and 2-C). The housekeeping gene GAPDH was amplified for each experiment and used as the internal positive control. GAPDH mRNA levels were not significantly changed by different treatments (Fig. 2-B ).
This article has not been copyedited and formatted. The final version may differ from this version. To investigate if protein levels for these enzymes were affected by the treatment, western blot experiments were conducted using the same experimental conditions. We found that the levels of iNOS, COX-2 and MMP-9 proteins were increased by the treatment with the activating cocktail and this enhancement was abolished in the presence of dexamethasone (Fig. 3A-C) .
The enzymatic activities of iNOS, COX-2 and MMP-9 were also characterized. The activity of Ca 2+ -independent NOS in unstimulated (Sham) VSM was 12.4±0.6 pmol/mg protein/min (Fig 4A) . Cell induction resulted in a significant increase in the activity of this enzyme to 24.4±2.6 pmol/mg protein/min. Ca 2+ -dependent NOS activity was not detectable under these conditions, indicating that neither nNOS or eNOS were expressed in A7r5.
The activity of COX-2, as measured by prostaglandin E 2 (PGE 2 ) levels, was significantly increased following cell induction, (Fig. 4-B) . The gelatinolytic activity of MMP-9, but not MMP-2, was markedly upregulated by the activating cocktail (Fig. 4-C) . Dexamethasone abolished increases in iNOS, COX-2 and MMP-9 activities caused by cell induction (Fig. 4A-C) .
Effects of L-NAME on COX-2 and MMP-9 transcription: Inhibition of NOS with L-NAME (300µM) exerted no significant effect on iNOS mRNA expression in activated cells (Fig. 5-A) . In contrast, COX-2 and MMP-9 transcription was downregulated by this inhibitor (Fig. 5-A) . L-NAME did not change the expression levels of the positive control GAPDH. To quantify the changes detected using RT-PCR, real time PCR analysis was conducted for COX-2 and MMP-9 mRNAs. It was found that COX-2 was upregulated by 2.3 fold and that this upregulation could be inhibited to lower than control levels by either Dex or L-NAME. MMP-9 mRNA levels were upregulated with the activating cocktail by approximately 11.7 times and they were significantly reduced in the presence of Dex or L-NAME (Fig. 5-B) .
Effects of SOD and MnTMPyP on MMP-9 mRNA: To investigate if superoxide and possibly peroxynitrite (Patel et al., 1999) were involved in MMP-9 regulation by iNOS the scavenger of superoxide, superoxide dismutase (SOD), was tested on A7r5 cells induced with the activating cocktail. SOD at concentrations of 100, 10, 5, 1, and 0.5 U/mL exerted no significant effects on MMP-9 mRNA induction ( Fig. 6-A) . These concentrations of SOD effectively blocked superoxide generation by xanthine oxidase (Ohara et al., 1993) (data not shown). The membrane-soluble SOD mimetic MnTMPyP did not modify significantly the This article has not been copyedited and formatted. The final version may differ from this version. JPET #050385 12 upregulation of these enzymes indicating that neither superoxide nor peroxynitrite are involved in this mechanism ( Fig. 6-B) .
Effects of 1H-[1,2,4] Oxadiazolo [4,3-a] quinoxalin-1-one (ODQ) and 8-bromo-cGMP on MMP-9 mRNA regulation: To study the involvement of cyclic guanosine monophosphate (cGMP) in MMP-9 mRNA regulation ODQ, an inhibitor of soluble guanylate cyclase (sGC) was used. ODQ effectively decreased, in a concentration dependent fashion, the levels of MMP-9 mRNA (Fig. 7-A) . 8-bromo-cGMP, a soluble analog of cGMP, reversed the effect of ODQ (Fig. 7-B ).
This article has not been copyedited and formatted. The final version may differ from this version. We have investigated the interactions between iNOS, COX-2 and MMP-9, three pro-inflammatory enzymes that are induced in the vasculature during acute inflammatory reactions such as septicemia and septic shock (Beckman et al., 1990; Gomez-Jimenez et al., 1995; Beckman and Koppenol, 1996; Szabo et al., 1996; Pugin et al., 1999; Titheradge, 1999; Ermert et al., 2000; Fischer et al., 2000; Strong et al., 2000; Opdenakker, 2001; Dubois et al., 2002; Albert et al., 2003) . We have studied these interactions using rat smooth muscle vascular cells, which were induced by LPS, IFN-γ and PMA. Under experimental conditions used, the inducing agents resulted in upregulation of enzyme expression at transcriptional (mRNA), translational (protein) and activity (product generation or substrate degradation) levels. We have further validated our model of simultaneous induction of iNOS, COX-2 and MMP-9 using dexamethasone, a potent glucocorticoid known to inhibit many pathways of inflammation . As expected this drug treatment efficiently reduced the expression of iNOS, COX-2 and MMP-9 ( Fig. 2-B and 3A-C).
We then used RT-PCR to study the effects of blockade of NOS with L-NAME on MMP-9 and COX-2 mRNA levels. Inhibition of NOS with L-NAME downregulated the expression of COX-2. This is not surprising since NO is known to stimulate the activity of cyclooxygenase (Salvemini et al., 1993) and NO stimulates COX-2 mRNA expression in rat mesangial cells (Tetsuka et al., 1996) . Interestingly, we have found that MMP-9 mRNA upregulation was inhibited by L-NAME showing that MMP-9 induction is NO-dependent by a NOSdependent mechanism. This observation was confirmed and quantified by real time PCR experiments (Fig. 5-A ).
Initially it was thought that NO-effects could potentially be mediated through either nitrosylation, oxidation, nitration or a combination of these reactions, since these non-specific reactions are common in inflammatory settings. Peroxynitrite is one of the most reactive biochemical fates of NO and in many studies has been described as a signaling molecule that acts through tyrosine nitration (Patel et al., 1999) . For this reason, SOD and membrane-soluble SOD mimetic MnTMPyP were used to investigate ONOO -effects on the MMP-9 induction pathway. The treatments did not modify the MMP-9 gene control mechanism suggesting that ONOO -was not involved in this process (Fig. 6-A and B) . A second pathway by which NO could be acting was through soluble guanylate cyclase. Our results indicated that in the presence of ODQ, an inhibitor of soluble guanylate cyclase, the MMP-9 mRNA returned to its basal levels. Furthermore, the effect produced by This article has not been copyedited and formatted. The final version may differ from this version. Fig. 7-B) . These data imply that the soluble guanylate cyclase was the main pathway for NO-dependent MMP-9 gene upregulation.
Recently, in contrast to our results on enhancement of MMP-9 (Eberhardt et al., 2000) , using rat mesangial cells found that endogenous or exogenously provided NO decreased MMP-9 gene expression. They also showed that administration of another inhibitor of NOS, L-NMMA increased MMP-9 mRNA expression. NO can reduce t1/2 life of MMP-9 mRNA (Eberhardt et al., 2002) as well as S-nitrosylate NF-kB (Marshall and Stamler, 2001) , two mechanisms by which NO may modulate MMP-9 expression. By contrast NO has been found to increase MMP-9 activity through s-nitrosylation (Gu et al., 2002) .
Interestingly, pharmacological studies using L-NAME (inhibitor of NOS) and AMD6221 (NO scavenger) yielded contradictory data on MMP-9 activity. The administration of L-NAME to neonatal hyperoxic rats increased activity of MMP-9 (Radomski et al., 1998) , while NO scavenging decreased MMP-9 activity elevated by extracorporeal circulation (Mayers et al., 2003) . These complex effects of inhibition by NO of expression and activity of MMP-9 likely reflect dual nature of NO as inflammatory-inhibitor and inflammatory-mediator (Droge, 2002) .
The conflicting results on enhancement or inhibition of MMP-9 illustrate the complexity of the interactions of NO with cell signalling cascades. Factors such as cell type, stimulation time and stimulatory cocktail likely contribute to some of the differences observed. In our study we examined the expression of MMP-9 mRNA after 12h of treatment using a cocktail containing LPS, IFN-γ and PMA and observed that serum starved cells even in the absence of the stimulatory cocktail (control conditions) began to synthesize MMP-9 mRNA by 24h. These results were further validated by a time course of MMP-9 activity, using zymography, in which 12h was clearly the optimal induction time as described above. It is possible that in settings where cells have been stimulated for 24 to 72h, as done in several of the studies outlined above (Eberhardt et al., 2000; Eberhardt et al., 2002) , the levels of NO are different than we have observed. A time course of NO 2 -formation using the Griess reaction showed that there was a significant increase in nitrite formation after 24h
and after 48h of cell activation whereas nitrite formation could not be detected in control conditions or when activated cells were co-treated with either L-NAME or 1400W.
Thus, NO may function through alternative pathways to reduce MMP-9 levels, e.g. through oxidation of MMP-9 mRNA. Our findings could be interpreted in terms of early and late NO-mediated events, in which The list of genes that are upregulated via soluble guanylate cyclase-mediated pathways includes only COX-2, TNF, PAI-1, FLT-1, MKP-1 (Pfeilschifter et al., 2001 ) and now MMP-9. The exact mechanism by which cGMP exerts its transcription regulatory functions has not been fully elucidated. Activated soluble guanylate cyclase synthesizes cGMP, which in turn alters the activity of three main target proteins: (1) cGMP-regulated ion channels, (2) cGMP-regulated phosphodiesterases, and (3) cGMP-dependent protein kinases (PKG).
Several lines of evidence appear to involve PKG as the mediator of soluble guanylate cyclase action on MMP-9 gene (Gudi et al., 1996; Gudi et al., 1997; Gudi et al., 1999) . More recent studies have shown that PKG-mediated gene regulation takes place via activation of members of the MAPK protein family including Raf1, ERK1/2 and synthesis of c-jun. Interestingly, protein kinase C (PKC) has been shown to regulate transcription of MMP-9 gene via stimulation of ERK1/2 pathway (Genersch et al., 2000; Lee et al., 2003) .
This PKC-like behavior may partially explain how increased soluble guanylate cyclase activity upregulates MMP-9 gene. However, under conditions of our experiments stimulation of PKG, but not PKC, appears to be necessary for MMP-9 gene induction since despite the continuous presence of PMA, a known stimulator of PKC (Ron and Kazanietz, 1999) , the blockade of soluble guanylate cyclase pathway with ODQ abolished MMP-9 gene transcription.
The precise mechanisms involved in soluble guanylate cyclase-mediated MMP-9 gene induction remain to be studied. It is important to note that our current understanding of regulatory mechanisms of the MMP-9
promoter is very limited. Transcription Elements Search System (TESS) analysis of 1300bp of the rat MMP-9
promoter reveals a complex picture of multiple binding sites for more than 200 different transcription factors.
We are currently investigating the relevance of a novel PKG/PKA target, which we have identified as a possible MMP-9 repressor.
The results of our experiments show that the NO-cGMP pathway plays a crucial role in MMP-9 gene regulation. The pharmacological significance of our findings remains to be studied.
This article has not been copyedited and formatted. The final version may differ from this version. were obtained for the COX-2 protein at 74 kDa. A second band at a higher molecular weight also appeared only in activated conditions and was suspected to be due to antibody cross-reactivity (n = 3). Statistical significance: P<0.01 (**), ( † †); P<0.001 (***), ( † † †). Zymography was performed to measure the gelatinolytic activity of MMP-9. The pro and active forms of MMP-9 were detected at 92 and 88 kDa respectively. At 72 and 62 kDa the pro and active forms of MMP-2 were also detected. MMP-2 is a constitutive metalloproteinase that remained relatively unchanged despite different treatments. Densitometric analysis for MMP-9 and MMP-2 revealed a highly significant upregulation in activity of MMP-9 in activated cells, whereas dexamethasone (Dex) inhibited this upregulation to near control levels (n = 3). Statistical significance: P<0.05 (*), ( †); P<0.01 (**), ( † †); P<0.001 (***), ( † † †).
Fig. 5:
Effect of L-NAME treatment on levels of mRNA for iNOS, COX-2 and MMP-9. (A) RT-PCR was performed using both Dexamethasone (Dex) and L-NAME as pharmacological tools. The positive control GAPDH was constant for each treatment. L-NAME had an inhibitory effect obvious for COX-2 and for MMP-9 (n = 3). (B) Real time PCR was performed to validate and quantify the RT-PCR findings. MMP-9 mRNA upregulation was found to be of 11.7 fold. This effect was inhibited by both, Dexamethasone and L-NAME to levels relatively close to sham (n = 3). (C) COX-2 upregulation during activation was found to be 2.3 fold and this effect was inhibited to lower than sham levels when treating with either Dexamethasone or L-NAME (n = 3). Statistical significance: P<0.05 (*), ( †); P<0.01 (**), ( † †). 
